# Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil

Study · id `cardio:ct-nct02017197` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02017197](<https://clinicaltrials.gov/study/NCT02017197>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02017197

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02017197. Randomized; triple masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02017197, source copy `cardio:ctgov-nct02017197-2016-11-23`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02017197, source copy `cardio:ctgov-nct02017197-2016-11-23`, retrieved 2026-10-26)
- Primary completion: 2016-08 (actual) (ClinicalTrials.gov record NCT02017197, source copy `cardio:ctgov-nct02017197-2016-11-23`, retrieved 2026-10-26)
- Completion: 2016-08 (actual) (ClinicalTrials.gov record NCT02017197, source copy `cardio:ctgov-nct02017197-2016-11-23`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT02017197, source copy `cardio:ctgov-nct02017197-2016-11-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02017197-2016-11-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Acronym: WARFA
- Condition: Atrial Fibrillation
- Intervention (Drug): Marevan®
- Intervention (Drug): generic warfarin #1
- Intervention (Drug): generic warfarin #2
- Lead sponsor: Federal University of São Paulo
- Lead sponsor class: OTHER
- Collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Federal University of São Paulo (`cardio:org-federal-university-of-sao-paulo`)
- Registry lists this organization as a collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo (`cardio:org-fundacao-de-amparo-a-pesquisa-do-estado-de-sao-paulo`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial (`cardio:pubmed-33793580`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 54e66a27ad0186610548197e281feb280ea6681fa9e5febeb55cd1986532edc9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
